Delivery Order SPE2DB22D2005-SPE2DB23FJRP5
Award Date 7/13/23
Potential Completion Date 7/14/23
Potential Value $7.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $7,157 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Lupron Depot-PED 30 mg 3-month kits. To be performed in Conshohocken, Pennsylvania from August 18-21, 2023, this order is in support of the DLA's medical supply chain responsibilities for the Department of Defense. As a top 20 Defense supplier, Amerisourcebergen will deliver the prescribed drugs to DLA distribution centers on behalf of its pharmaceutical distribution schedule...
- The Defense Logistics Agency awarded a $31,189.65 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Lupron Depot 11.25 mg 3-month kits. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania by September 8, 2023. No subcontractors or set aside designations were identified. This order...
- The Defense Logistics Agency awarded a $27,799 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Lupron Depot-PED 30 mg 3-month kits. This order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will deliver the Lupron Depot injections from its facility in Conshohocken, Pennsylvania by June 22, 2023 to support DLA's medical supply needs. No subcontractors or set...
- The Defense Logistics Agency awarded a $15,851.10 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Lupron Depot 11.25 mg 3-month kits. The order is for pharmaceutical products to support the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period from August 7 to August 8, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain...
- The Defense Logistics Agency awarded a $4,282 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Lupron Depot-Ped 11.25 mg kits. The order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania by July 3, 2023. No subcontractors or set aside designations were identified. This order supports...
- The Defense Logistics Agency awarded a $54,043.35 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562145958 Lupron Depot-PED 30 mg 3-month kits. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility in support of the Defense Logistics Agency's medical supply chain requirements. No major subcontractors or set aside designations were indicated. The delivery order was issued under an existing...
- The Defense Logistics Agency awarded a $33,117.62 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Lupron Depot 11.25 mg 3-month kits. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania over a period of one day from July 20th through July 21st, 2023. No subcontractors or set aside designations were identified....
- The Defense Logistics Agency awarded a $6,851.57 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Lupron Depot 11.25 mg 3-month kits. The order is associated with the Defense Logistics Agency's prime vendor pharmaceutical contracts program and supports the agency's mission to provide medical supplies and pharmaceuticals to all branches of the U.S. military. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required...
- The Defense Logistics Agency awarded a $5,777.62 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Lupron Depot 11.25 mg 3-month kits. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania from August 7-8, 2023. No subcontractors or set aside designations were identified. This order supports DLA's mission to...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at twelve thousand five hundred twenty-five dollars and forty-three cents ($12,525.43) to Amerisourcebergen Drug Corporation for Lupron Depot 11.25 mg 3-month kits. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day, from September 26 to September 27, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation....
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB23FJRP5Delivery Order
The Defense Logistics Agency awarded a $7,273 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561490385 Lupron Depot-PED 30 mg 3-month kits. The order was placed under an existing prime vendor contract vehicle to support the Department of Defense pharmacy program. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from July 13 to July 14, 2023. No subcontractors or set aside designations were identified. The order continues DLA's procurement of pharmaceutical products to maintain military medical readiness.
Generated 12/22/23, 2:16 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 7/13/23 |